Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precedex in severe traumatic brain injury
NCT01007773Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in traumatic brain injury (TBI), sponsored by University of Maryland, Baltimore. Planned start Jan 2010; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01007773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007773.